See also this year's filing and all EDGAR filings for this company.
PDF Report 0001623526_2023_Stoke_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001623526, Stoke Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 244,070,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,675,000 |
| 3 | remainder_Assets | 5,322,000 |
| 4 | LiabilitiesCurrent | 31,394,000 |
| 5 | LiabilitiesNoncurrent | 39,824,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 59,223,803 |
| 9 | ResearchAndDevelopmentExpense | 143,497,570 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 12,405,000 |
| 12 | remainder_NetIncome | 2,267,430 |
| 13 | remainder_ComprehensiveNetIncome | -5,201,999 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 256,067,000 |
| 1 | Liabilities | 71,218,000 |
| 2 | Expenses | 202,721,373 |
| 3 | Revenues | 12,405,000 |
| 4 | StockholdersEquity | 184,849,000 |
| 5 | NetIncome | -188,048,943 |
| 6 | ComprehensiveNetIncome | -190,649,942 |
| 7 | BaseVar | 274,940,401 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.30 |
| 9 | EconomicCapitalRatio | 2.53 |
Edgar->Model Mapping
Feature Distribution
Change over Time
